Short Interest in Notable Labs, Ltd. (NASDAQ:NTBL) Drops By 19.3%

Notable Labs, Ltd. (NASDAQ:NTBLGet Free Report) was the recipient of a large decrease in short interest during the month of September. As of September 30th, there was short interest totalling 502,000 shares, a decrease of 19.3% from the September 15th total of 622,000 shares. Currently, 9.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 80,900 shares, the short-interest ratio is presently 6.2 days.

Notable Labs Price Performance

NASDAQ:NTBL traded up $0.02 during mid-day trading on Friday, reaching $0.40. The stock had a trading volume of 17,217 shares, compared to its average volume of 54,994. Notable Labs has a one year low of $0.38 and a one year high of $10.08. The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.77 and a current ratio of 2.77. The firm has a 50 day moving average price of $0.49 and a two-hundred day moving average price of $0.78.

Notable Labs (NASDAQ:NTBLGet Free Report) last announced its quarterly earnings data on Wednesday, August 14th. The company reported ($0.55) earnings per share (EPS) for the quarter. On average, sell-side analysts forecast that Notable Labs will post -0.75 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, JMP Securities cut Notable Labs from an “outperform” rating to a “market perform” rating in a research note on Friday, September 20th.

Read Our Latest Stock Analysis on Notable Labs

Notable Labs Company Profile

(Get Free Report)

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment.

See Also

Receive News & Ratings for Notable Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Notable Labs and related companies with MarketBeat.com's FREE daily email newsletter.